Routine electronic symptom monitoring for adults on dialysis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

F-SWIFT is a multicenter, randomized controlled trial nested in the French REIN dialysis registry that compares routine electronic symptom monitoring to usual care in adult dialysis patients. Participants in the intervention arm complete the IPOS‑Renal questionnaire every three months for 18 months with results systematically reported to treating clinicians, while HRQoL is measured every six months with EQ-5D-5L and KDQoL-36 in both groups. The trial includes quantitative outcome analysis and a qualitative process evaluation to support transferability and potential large-scale deployment. Data are drawn from registry records and analyzed by biostatisticians and human and social sciences researchers at CHRU Nancy.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Symptom collection phase

The inclusion criteria for patients are as follows:

* Individuals who have received full information on the organization of the research and who have not objected to their participation and to the use of their data.
* Adults aged 18 and over
* Patients with end-stage renal disease treated by dialysis in participating dialysis units
* Patients able to answer questionnaires

Process evaluation phase

The inclusion criteria for healthcare professionals are as follows:

* Individuals who have received full information on the organization of the research and who have not objected to their participation and to the use of their data.
* Patients with end-stage renal disease treated by dialysis in participating dialysis units.
* Doctors and nurses working in the dialysis unit taking part in the study.

Exclusion Criteria:

The non-inclusion criteria for patients are as follows:

* Minors
* Patients under legal protection, guardianship or curatorship
* Patient not communicating or unable to give consent
* Patient not being treated in a dialysis unit participating in the study
* Patients being treated temporarily in a participating dialysis unit (respite care, vacationers, etc.)
* Patient with cognitive disorders
* Patient unable or unwilling to answer questionnaires

The non-inclusion criteria for healthcare professionals are as follows:

* Non-voluntary healthcare professional
* Healthcare professional not working in the participating facility

Where it's running

• Altir
  Vandœuvre-lès-Nancy, France Recruiting
• CHRU Nancy
  Vandœuvre-lès-Nancy, France Recruiting
• Maison du Rein AURAD Aquitaine
  Gradignan, France Not yet recruiting

Study contacts

• Principal investigator: Francis GUILLEMIN, MD, PhD — Centre d'Investigation Clinique - Epidémiologie Clinique 1433
• Study coordinator: Nadine JUGE
• Email: n.juge@chru-nancy.fr
• Phone: 03 83 15 35 39

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Ribupatide PK in People with Kidney Impairment

  This study tests how a single shot of ribupatide behaves in the body for people with severe kidney problems compared to those with normal kidney function.

  Recruiting at 2 sites Phase 1 Kailera · Orlando, Florida and 1 other locations · NCT07793929

• Intradiay dialysis exercise to improve posture in adults with end-stage kidney disease

  This study tests whether a 12-week supervised exercise program done during dialysis can improve posture in adults on maintenance hemodialysis.

  Recruiting Pardis Specialized Wellness Institute · Isfahan · NCT07720401

• Pumpkin seed oil for people on hemodialysis

  This study tests whether taking pumpkin seed oil daily for 3 months helps reduce inflammation and improve-related lab markers in people with end-stage kidney disease on dialysis.

  Recruiting Al-Mustansiriyah University · Baghdad, Karkh · NCT07710183

• Porcine thymokidney transplant for end-stage renal disease

  This study tests whether a GalKO porcine thymokidney transplant can keep kidney function without dialysis in adults with end-stage kidney disease who are unlikely to get a standard donor kidney soon.

  Recruiting Phase 1 Xeno Holdings (US), LLC dba ChoironeX · New York, New York and 1 other locations · NCT07696962

• How inflammatory diseases change the way your body handles medicines.

  This study will see if inflammatory conditions like type 2 diabetes, IBD, or end-stage kidney disease change how common medicines are processed and increase the chance of side effects.

  Recruiting Indiana University · Indianapolis, Indiana · NCT07360938

• CRISPR-edited donor kidney transplant to reduce rejection risk

  This trial will see if donor kidneys edited with CRISPR to turn off key HLA genes can lower rejection in adults with end-stage kidney disease receiving transplants.

  Recruiting Phase 1/2 American Organ Transplant and Cancer Research Institute LLC · Beijing, Changping · NCT07053462

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.